Answers are grounded in this paper and cite their sources.
Stress cytokines tumor necrosis factor α, interleukin-1β and interleukin-6 modulate the activity of a variety of cell types including osteoblasts, and are involved in the pathogenesis of several rheumatic diseases associated with systemic bone loss. We have studied the expression of interleukin-6 induced by interleukin-1β and tumor necrosis factor α in the osteoblast-like cell line MG-63, derived from a human osteosarcoma. We have observed marked differences in the regulation of interleukin-6 gene expression by tumor necrosis factor α or interleukin-1β. at the level of mRNA steady state and stability and cytokine secretion. In addition, N-acetyl cysteine, a scavenger of reactive oxygen species, inhibits activation of NF-κB and induction of interleukin-6 by tumor necrosis factor α, being ineffective on interleukin-1 β activity. These data illustrate the action of stress cytokines on a cell line widely used in in vitro studies as a reliable model of osteoblast response to cytokines involved in bone resorbing diseases, an important issue for developing new strategies for treatments of bone diseases.
No takes yet. Share an insight, caveat, or question.
Furia et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: